SUGAR LAND--March 7, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The Pharmaceutical-Biotech Industry is on track to complete construction on 101 North American capital and MRO (maintenance, repair and operations) projects during the first quarter of 2017. A recent survey of reported projects in Industrial Info's Pharmaceutical-Biotech Online Platform reveals that the projects have a total investment value (TIV) of $2.29 billion.

Within this article: Details on some of the projects set to wrap up by the end of the quarter.

Companies featured: AstraZeneca plc (NYSE:AZN), United Therapeutics Corporation (NASDAQ:UTHR), GlaxoSmithKline (NYSE:GSK